These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 22210352)
61. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay. Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347 [TBL] [Abstract][Full Text] [Related]
62. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk. Fan CD; Fu XY; Zhang ZY; Cao MZ; Sun JY; Yang MF; Fu XT; Zhao SJ; Shao LR; Zhang HF; Yang XY; Sun BL Sci Rep; 2017 Jul; 7(1):6465. PubMed ID: 28743999 [TBL] [Abstract][Full Text] [Related]
63. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines. Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805 [TBL] [Abstract][Full Text] [Related]
65. Design, synthesis, and biological evaluation of novel derivatives of dithiodiglycolic acid prepared via oxidative coupling of thiols. Bakulina O; Bannykh A; Jovanović M; Domračeva I; Podolski-Renić A; Žalubovskis R; Pešić M; Dar'in D; Krasavin M J Enzyme Inhib Med Chem; 2019 Dec; 34(1):665-671. PubMed ID: 30746961 [TBL] [Abstract][Full Text] [Related]
66. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263 [TBL] [Abstract][Full Text] [Related]
67. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation. Watson WH; Heilman JM; Hughes LL; Spielberger JC Biochem Biophys Res Commun; 2008 Apr; 368(3):832-6. PubMed ID: 18267104 [TBL] [Abstract][Full Text] [Related]
68. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Chen X; Chen X; Zhang X; Wang L; Cao P; Rajamanickam V; Wu C; Zhou H; Cai Y; Liang G; Wang Y Redox Biol; 2019 Feb; 21():101061. PubMed ID: 30590310 [TBL] [Abstract][Full Text] [Related]
69. Redox activation of Fe(III)-thiosemicarbazones and Fe(III)-bleomycin by thioredoxin reductase: specificity of enzymatic redox centers and analysis of reactive species formation by ESR spin trapping. Myers JM; Cheng Q; Antholine WE; Kalyanaraman B; Filipovska A; Arnér ES; Myers CR Free Radic Biol Med; 2013 Jul; 60():183-94. PubMed ID: 23485585 [TBL] [Abstract][Full Text] [Related]
70. Inducing ubiquitination and degradation of TrxR1 protein by LW-216 promotes apoptosis in non-small cell lung cancer via triggering ROS production. Wang R; Zhong L; Wang T; Sun T; Yang J; Liu X; Wu Y; Guo Q; Gao Y; Zhao K Neoplasia; 2024 Jul; 53():101004. PubMed ID: 38733769 [TBL] [Abstract][Full Text] [Related]
71. Acrolein-induced activation of mitogen-activated protein kinase signaling is mediated by alkylation of thioredoxin reductase and thioredoxin 1. Randall MJ; Spiess PC; Hristova M; Hondal RJ; van der Vliet A Redox Biol; 2013; 1(1):265-75. PubMed ID: 24024160 [TBL] [Abstract][Full Text] [Related]
72. Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo. Tan Q; Li J; Yin HW; Wang LH; Tang WC; Zhao F; Liu XM; Zeng HH Invest New Drugs; 2010 Jun; 28(3):205-15. PubMed ID: 19271154 [TBL] [Abstract][Full Text] [Related]
73. Targeting the Selenoprotein Thioredoxin Reductase 1 for Anticancer Therapy. Arnér ESJ Adv Cancer Res; 2017; 136():139-151. PubMed ID: 29054416 [TBL] [Abstract][Full Text] [Related]
74. Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells. Sachweh MC; Stafford WC; Drummond CJ; McCarthy AR; Higgins M; Campbell J; Brodin B; Arnér ES; Laín S Oncotarget; 2015 Jun; 6(18):16488-506. PubMed ID: 26029997 [TBL] [Abstract][Full Text] [Related]
75. Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction. Poerschke RL; Moos PJ Biochem Pharmacol; 2011 Jan; 81(2):211-21. PubMed ID: 20920480 [TBL] [Abstract][Full Text] [Related]
76. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ES; Spyrou G J Biol Chem; 2004 Dec; 279(52):54510-7. PubMed ID: 15471857 [TBL] [Abstract][Full Text] [Related]
77. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation. Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094 [TBL] [Abstract][Full Text] [Related]
78. Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism. Rajavel T; Banu Priya G; Suryanarayanan V; Singh SK; Pandima Devi K Eur J Pharmacol; 2019 Jul; 855():112-123. PubMed ID: 31059712 [TBL] [Abstract][Full Text] [Related]
79. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress. Park WH Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420 [TBL] [Abstract][Full Text] [Related]
80. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest. Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]